Opiant Pharmaceuticals Inc. is benefiting from the government's desire to develop treatments for possible terrorist attacks involving fentanyl or other opioids.
The Biomedical Advanced Research and Development Authority (BARDA), part of HHS's Office of the Assistant Secretary for Preparedness and Response,...






